Joint Injections - Hips
Specialist Hip Joint Injections in London
At Rejuvence Clinic, we provide diagnosis-led hip injection treatments for pain, stiffness and reduced mobility. All injections are selected following careful clinical assessment and, where appropriate, ultrasound guidance, supporting safe symptom relief and effective rehabilitation.
Hip Joint Injections
Hip pain is a common cause of reduced mobility and functional limitation. Symptoms may arise from inflammation of the soft tissues around the hip or from degenerative changes within the hip joint itself. While many patients improve with physiotherapy, weight management and activity modification, hip injections can play a role in symptom management when pain persists.
At Rejuvence Clinic, hip injections are offered as part of an evidence-based treatment plan tailored to the underlying diagnosis and individual patient needs.
Hip Conditions We Treat
Injection therapy may be considered for:
Corticosteroid (Steroid) Injections
Corticosteroid injections are commonly used to manage inflammatory hip conditions. They work by reducing inflammatory activity, which can help relieve pain and improve function in the short to medium term. For trochanteric bursitis, steroid injections are well supported by clinical evidence and may reduce lateral hip pain when physiotherapy alone has not been sufficient. In hip osteoarthritis, steroid injections may be used to manage pain flares and improve mobility, particularly in patients who are not yet candidates for surgery or are seeking non-surgical symptom control.
Steroid injections are used judiciously and are typically combined with physiotherapy and lifestyle modification rather than used as a long-term standalone solution.
Summary – Steroid Injections- Reduce inflammation and pain
- Strong evidence for trochanteric bursitis
- Used in hip arthritis for symptom flares
- Short- to medium-term relief
Hyaluronic Acid Injection (Ostenil Plus®)
Hyaluronic acid injections aim to improve joint lubrication and reduce mechanical pain associated with cartilage wear. Ostenil Plus is a high-purity formulation used in degenerative joint conditions.
In the hip, hyaluronic acid injections may be considered for osteoarthritis, particularly when a non-steroidal option is preferred. Evidence suggests that some patients experience improvements in pain and function, although responses can vary. Hyaluronic acid injections are not routinely used for trochanteric bursitis, as this condition primarily involves soft tissue inflammation rather than joint degeneration.
Summary – Hyaluronic Acid- Improves joint lubrication
- Considered in hip osteoarthritis
- Non-steroidal treatment option
- Variable response depending on disease stage
Hydrodistension (Not Routinely Used for Hip Conditions)
Hydrodistension is primarily used in frozen shoulder and is not routinely performed for trochanteric bursitis or hip arthritis. It is not considered a standard treatment for hip joint pathology.
Summary – Hydrodistension- Not routinely used for hip conditions
- Alternative treatments preferred
- Diagnosis-led decision making
Aspiration (Limited Role in Hip Conditions)
Aspiration involves removal of excess fluid from a joint or bursa. In hip conditions, aspiration is less commonly performed due to the deep location of the joint but may be considered in selected cases for diagnostic or symptomatic reasons, such as suspected inflammatory or infective processes.
Summary – Joint Aspiration- Limited role in routine hip pain management
- Used selectively for diagnostic or inflammatory indications
- Specialist assessment required
Autologous Exosome-Based Injection (ExoSmart™)
Autologous exosome-based injections are an emerging treatment approach using biologically active extracellular vesicles derived from a patient’s own blood sample. These vesicles are involved in cellular signalling and inflammatory modulation.
Clinical interest includes degenerative joint conditions such as hip osteoarthritis, particularly in patients seeking non-surgical options. Research is ongoing, outcomes vary, and this treatment is offered only following careful assessment and informed discussion.
Summary – Autologous Exosome Injection- Patient-derived, emerging treatment option
- Considered in selected cases of hip osteoarthritis
- Evidence base is evolving
- Individualised patient selection
Your Hip Injection Specialist
Mr Ameerudhin Ahamed
MBBS, MRCS, FRCS, PG Cert (MSK USGI) Consultant Trauma & Orthopaedic Surgeon Barts Health NHS Trust
Mr Ameerudhin Ahamed is a GMC-registered consultant orthopaedic surgeon with extensive experience in musculoskeletal medicine and ultrasound-guided injections. He qualified with an MBBS in 2000 and has held full GMC registration since 2007.
He completed advanced postgraduate training in Trauma and Orthopaedic Surgery across major London hospitals, including the Royal National Orthopaedic Hospital, Stanmore, and was awarded FRCS (Trauma & Orthopaedics) in 2016. He also holds a Postgraduate Certification in Musculoskeletal Ultrasound-Guided Injection.
At Rejuvence Clinic, Mr Ahamed provides specialist assessment and ultrasound-guided hip injections, integrating injection therapy into a broader care plan that may include physiotherapy, activity modification and onward referral where appropriate.
Relief varies between individuals. Some patients experience improvement for weeks to months, particularly when combined with physiotherapy.
Injections help manage symptoms but do not reverse arthritis. They are used to support function and quality of life.
Yes, ultrasound guidance is used where appropriate to improve accuracy and safety.
Yes. Physiotherapy is often recommended alongside injection therapy to optimise outcomes.
References & Further Reading
1. NICE CKS. Greater trochanteric pain syndrome: management. 2. NICE CKS. Osteoarthritis: care and management. 3. Brinks A et al. Corticosteroid injection for greater trochanteric pain syndrome. Ann Fam Med. 4. McCabe PS et al. Intra-articular corticosteroid injections for hip osteoarthritis. Cochrane Database Syst Rev. 5. Bannuru RR et al. Hyaluronic acid in osteoarthritis. Osteoarthritis and Cartilage.
